|Systematic (IUPAC) name|
|Protein binding||> 95%|
|CAS Registry Number|
|Molecular mass||352.47 g/mol|
|Melting point||83 °C (181 °F)|
Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s. It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.
Anileridine is no longer manufactured in the US or Canada.
Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours. It is mostly metabolized by the liver.
- U.S. Patent 2,897,204
- "Discontinued Prescription Drug Products". Canadian Pharmacists' Association. Retrieved 28 July 2008.
- "Pharmaceutical Information - LERITINE". RxMed. Retrieved 16 June 2010.
- "Anileridine Consumer Information". MedicineNet. Retrieved 28 July 2008.